Grants per year
Personal profile
Research Interests
I became interested in the field of allergy/immunology (A/I) as a medical student at Northwestern. After residency, I decided to pursue a career in A/I. During my training, I worked with leaders in food allergy and childhood asthma so I was attracted to these exciting areas in which mechanistic discoveries and advances in clinical therapeutics were being made. I have had a fulfilling career as a faculty member at NUFSM and attending physician at Lurie Children's for my entire career and as Division Head of A/I since 2004.
Food Allergy: My interests include pathogenesis of allergen sensitization and food allergy, as well as conducting clinical trials of immunomodulatory interventions for food allergy. Asthma: My interests lie in understanding the factors which contribute to health disparities, particularly in inner-city children with asthma and its greater morbidity/mortality as compared to non-inner city populations. I am especially interested in the relationships between allergen sensitization, exposure and morbidity for cockroach, rodents and fungi. I have also been engaged in clinical trials to improve therapy and address gaps in childhood asthma.
Food allergy, especially IgE-mediated food allergy including food-induced anaphylaxis. Childhood asthma, especially severe persistent asthma and labile asthma with frequent exacerbations
Certifications and Licenses
Internal Medicine | |
Allergy & Immunology |
Training Experience
1988 | Residency, North Shore University Hospital |
1991 | Fellowship, Johns Hopkins Hospital |
Education/Academic qualification
Medicine, MD, Northwestern University
… → 1985
Research interests keywords
- Asthma
- Food Allergy
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
-
REAL-WORLD AR101MARKET-SUPPORTING EXPERIENCE STUDY IN PEANUT-ALLERGIC CHILDREN, ACTIVE TREATMENT ARM OPEN-LABEL EXTENSION STUDY (RAMSES OLE)
Robison, R. G. (PD/PI), Makhija, M. M. (Co-Investigator) & Pongracic, J. A. (Co-Investigator)
2/28/18 → 8/31/50
Project: Research project
-
ARC-008: A Multicenter, Open-label, Long-term Safety Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects who Participated in a Prior AR101 Study
Makhija, M. M. (PD/PI), Pongracic, J. A. (Co-Investigator) & Robison, R. G. (Co-Investigator)
12/8/17 → 8/31/50
Project: Research project
-
OPEN-LABEL FOLLOW-UP STUDY OF THE PEPITES STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF VIASKIN® PEANUT (PEOPLE STUDY)
Pongracic, J. A. (PD/PI), Makhija, M. M. (Co-Investigator) & Robison, R. G. (Co-Investigator)
3/7/17 → 8/31/50
Project: Research project
-
A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy
Inner-City Asthma and Childhood Asthma in Urban Settings Consortia, Sep 2024, In: Journal of Allergy and Clinical Immunology. 154, 3, p. 735-744.e10Research output: Contribution to journal › Article › peer-review
-
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma
National Heart, Lung, and Blood Institute AsthmaNet, Apr 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 4, p. 960-969.e6Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis
National Institute of Allergy and Infectious Disease's Inner City Asthma Consortium, Jan 2023, In: The Lancet Planetary Health. 7, 1, p. e33-e44Research output: Contribution to journal › Article › peer-review
Open Access47 Scopus citations -
Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
Davis, C. M., Lange, L., Beyer, K., Fleischer, D. M., Ford, L., Sussman, G., Oriel, R. C., Pongracic, J. A., Shreffler, W., Bee, K. J., Campbell, D. E., Green, T. D., Lambert, R., Peillon, A. & Bégin, P., Feb 2023, In: Journal of Allergy and Clinical Immunology: Global. 2, 1, p. 69-75 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Greenhawt, M., Sindher, S. B., Wang, J., Osullivan, M., Du Toit, G., Kim, E. H., Albright, D., Anvari, S., Arends, N., Arkwright, P. D., Begin, P., Blumchen, K., Bourrier, T., Brown-Whitehorn, T., Cassell, H., Chan, E. S., Ciaccio, C. E., Deschildre, A., Divaret-Chauveau, A. & Dorris, S. L. & 46 others, , 2023, In: New England Journal of Medicine. 388, 19, p. 1755-1766 12 p.Research output: Contribution to journal › Article › peer-review
50 Scopus citations